Table 1.
Clinical characteristics in PD
| PD (n=146) | |
|---|---|
| Age (years, mean (SD)) | 63.68 (10.69) |
| Sex (male, female) | 64;82 |
| HTN (number, percentage) | 54 (40%) |
| DM (number, percentage) | 19 (13%) |
| Hypercholesterolemia (number, percentage) | 31 (21.2%) |
| Smoking (number, percentage) | 4 (2.7%) |
| Medications (number, percentage) | 52 (35.6%) |
| UPDRS I, mean (SD) | 3.41 (2.47) |
| UPDRS II, mean (SD) | 10.21 (7.81) |
| UPDRS III, mean (SD) | 24.91 (16.37) |
| UPDRS total, mean (SD) | 38.54 (24.92) |
| Modified Hoehn and Yahr scale, mean (SD) | 1.94 (1.14) |
| Schwab and England ADL scale, mean (SD) | 82.96 (17.91) |
| PWMH grading, mean (SD) | 1.16 (0.59) |
| DWMH grading, mean (SD) | 1.12 (0.66) |
| MMSE, mean (SD) | 24.42 (4.92) |
Among the clinical characteristics, age, UPDRS, Hoehn and Yahr scale, Schwab and England ADL scale, PWMH grading, DWMH grading and MMSE were analysed using frequency distribution
UPDRS The Unified Parkinson’s Disease Rating Scale, ADL Activity of daily living, PWMH Periventricular white matter hyperintensity, DWMH Deep white matter hyperintensity, MMSE Mini-Mental State Examination, HTN Hypertension, DM Diabetes Mellitus; Medications, was defined as Benzodiazepines